Literature DB >> 12639556

Ganglioside binding pattern of CD33-related siglecs.

Eugenia Rapoport1, Ilya Mikhalyov, Jiquan Zhang, Paul Crocker, Nicolai Bovin.   

Abstract

Our study deals with the interaction of CD33 related-siglecs-5,-7,-8,-9,-10 with gangliosides GT1b, GQ1b, GD3, GM2, GM3 and GD1a. Siglec-5 bound preferentially to GQ1b, but weakly to GT1b, whereas siglec-10 interacted only with GT1b ganglioside. Siglec-7 and siglec-9 displayed binding to gangliosides GD3, GQ1b and GT1b bearing a disialoside motif, though siglec-7 was more potent; besides, siglec-9 interacted also with GM3. Siglec-8 demonstrated low affinity to the gangliosides tested compared with other siglecs. Despite high structural similarity of CD33 related siglecs, they demonstrated different ganglioside selectivity, in particular to the Neu5Acalpha2-8Neu5Ac motif.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639556     DOI: 10.1016/s0960-894x(02)00998-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments.

Authors:  Gautam N Shenoy; Jenni Loyall; Charles S Berenson; Raymond J Kelleher; Vandana Iyer; Sathy V Balu-Iyer; Kunle Odunsi; Richard B Bankert
Journal:  J Immunol       Date:  2018-11-16       Impact factor: 5.422

2.  Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner.

Authors:  Marieke Bax; Mark L Kuijf; Astrid P Heikema; Wouter van Rijs; Sven C M Bruijns; Juan J García-Vallejo; Paul R Crocker; Bart C Jacobs; Sandra J van Vliet; Yvette van Kooyk
Journal:  Infect Immun       Date:  2011-04-18       Impact factor: 3.441

Review 3.  Sweet complementarity: the functional pairing of glycans with lectins.

Authors:  H-J Gabius; J C Manning; J Kopitz; S André; H Kaltner
Journal:  Cell Mol Life Sci       Date:  2016-03-08       Impact factor: 9.261

Review 4.  Siglec receptors and hiding plaques in Alzheimer's disease.

Authors:  Antero Salminen; Kai Kaarniranta
Journal:  J Mol Med (Berl)       Date:  2009-04-24       Impact factor: 4.599

5.  First Evidence for a Role of Siglec-8 in Breast Cancer.

Authors:  Anna Trebo; Nina Ditsch; Tom Degenhardt; Christina Kuhn; Martina Rahmeh; Elisa Schmoeckel; Doris Mayr; Bastian Czogalla; Thomas Kolben; Sarah Meister; Sven Mahner; Udo Jeschke; Anna Hester
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

Review 6.  The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors.

Authors:  Fabrice Cognasse; Kim Anh Nguyen; Pauline Damien; Archibald McNicol; Bruno Pozzetto; Hind Hamzeh-Cognasse; Olivier Garraud
Journal:  Front Immunol       Date:  2015-03-02       Impact factor: 7.561

7.  Glycan engagement dictates hydrocephalus induction by serotype 1 reovirus.

Authors:  Jennifer Stencel-Baerenwald; Kerstin Reiss; Bärbel S Blaum; Daniel Colvin; Xiao-Nan Li; Ty Abel; Kelli Boyd; Thilo Stehle; Terence S Dermody
Journal:  MBio       Date:  2015-03-03       Impact factor: 7.867

8.  Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes.

Authors:  Gitanjali Dharmadhikari; Katharina Stolz; Michael Hauke; Noel G Morgan; Ajit Varki; Eelco de Koning; Sørge Kelm; Kathrin Maedler
Journal:  Sci Rep       Date:  2017-04-05       Impact factor: 4.379

9.  Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10.

Authors:  Rosa Ester Forgione; Cristina Di Carluccio; Juan Guzmán-Caldentey; Rosa Gaglione; Filomena Battista; Fabrizio Chiodo; Yoshiyuki Manabe; Angela Arciello; Pompea Del Vecchio; Koichi Fukase; Antonio Molinaro; Sonsoles Martín-Santamaría; Paul R Crocker; Roberta Marchetti; Alba Silipo
Journal:  iScience       Date:  2020-06-02

10.  Platelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammation.

Authors:  Ilya Sotnikov; Tatyana Veremeyko; Sarah C Starossom; Natalia Barteneva; Howard L Weiner; Eugene D Ponomarev
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.